Also on Trial Friend:Idiopathic Pulmonary Fibrosis pageMatch Me
All 77 Idiopathic Pulmonary Fibrosis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes RegistryMost sites in Texas, North Carolina and CaliforniaRecruitingAges 21+Duke University42US sites
25 states - A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.Most sites in California, Pennsylvania and TexasRecruitingPhase 2Ages 40+AstraZeneca35US sites
22 states - An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)Most sites in New York, California and ConnecticutRecruitingPhase 2Ages 18+Avalyn Pharma32US sites
21 states - Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) TabletsMost sites in Florida, North Carolina and TexasRecruitingPhase 3Ages 40+Trevi Therapeutics31US sites
17 states - A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisMost sites in California, Texas and North CarolinaRecruitingPhase 2Ages 40+Rein Therapeutics20US sites
15 states - Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Most sites in Florida, New York and TexasRecruitingPhase 2Ages 40+Cumberland Pharmaceuticals18US sites
15 states - Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) TabletsMost sites in Florida, Oregon and TexasRecruitingPhase 3Ages 40+Trevi Therapeutics16US sites
10 states - Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)Most sites in Texas, Florida and TennesseeRecruitingPhase 3Ages 40+PureTech15US sites
9 states - Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisMost sites in Texas, Florida and AlabamaRecruitingPhase 2Ages 40+InSilico Medicine Hong Kong12US sites
9 states - Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary FibrosisMost sites in Alabama, Michigan and VirginiaRecruitingPhase 2Ages 40+AbbVie10US sites
7 states - A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary FibrosisMost sites in Alabama, Florida and MissouriRecruitingPhase 2Ages 40+Chiesi Farmaceutici S.p.A.6US sites
6 states - Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailureOnly in PennsylvaniaRecruitingPhase 1/2Ages 18-60Paul Szabolcs2US sites
- Study of ORJ-001 for the Treatment of IPFMost sites in Florida and PennsylvaniaRecruitingPhase 2Ages 40+Oorja Bio2US sites
2 states - A Study of the Natural Progression of Interstitial Lung Disease (ILD)Only in IllinoisRecruitingAges 18+University of Chicago1US site
- Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisOnly in MassachusettsRecruitingPhase 2Ages 18-80Peter Caravan1US site
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesOnly in New YorkRecruitingAges 18+Weill Medical College of Cornell University1US site
- Dose-Escalation Study of Artesunate Patients With IPFOnly in CaliforniaRecruitingPhase 1Ages 40+Joseph C. Wu1US site
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)Only in PennsylvaniaRecruitingAges 18+University of Pittsburgh1US site
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Only in PennsylvaniaRecruitingAges 18+University of Pittsburgh1US site
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)Only in North CarolinaRecruitingPhase 2Ages 18-100National Institute of Environmental Health Sciences (NIEHS)1US site
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Idiopathic Pulmonary Fibrosis trials in the US, and what stage they are in
Of the 36 Idiopathic Pulmonary Fibrosis trials with a US site, 5 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 18 of them. The remaining 13 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 14 of them, and universities, hospitals, foundations and government groups run 22. The sponsors with the most are Trevi Therapeutics (2), University of Alabama at Birmingham (2) and University of Pittsburgh (2). The most recently listed one first appeared on ClinicalTrials.gov on November 9, 2026.
Idiopathic Pulmonary Fibrosis trials in the US, state by state
Of the 36 Idiopathic Pulmonary Fibrosis trials with a US site, 1 accepts children under 18. Its open sites are in Pennsylvania, Florida and Alabama. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 27 states
US hospitals running the most Idiopathic Pulmonary Fibrosis trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Idiopathic Pulmonary Fibrosis.
- University of UtahSalt Lake City, Utah5 trials
- Massachusetts General HospitalBoston, Massachusetts4 trials
- Medical University of South CarolinaCharleston, South Carolina4 trials
- Baylor College of MedicineHouston, Texas3 trials
- Clinical Research Associates of Central PADuBois, Pennsylvania3 trials
- Icahn School of Medicine at Mount SinaiNew York, New York3 trials
- Southeastern Research CenterWinston-Salem, North Carolina3 trials
- Temple UniversityPhiladelphia, Pennsylvania3 trials
- Thomas Jefferson UniversityPhiladelphia, Pennsylvania3 trials
- University of Alabama at BirminghamBirmingham, Alabama3 trials
Help getting to an Idiopathic Pulmonary Fibrosis trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding an Idiopathic Pulmonary Fibrosis trial near you
Are there Idiopathic Pulmonary Fibrosis clinical trials near me?
As of November 13, 2026, 77 Idiopathic Pulmonary Fibrosis clinical trials are recruiting now and 30 are not yet recruiting. In the US, 36 of them have at least 1 open site, across 36 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Idiopathic Pulmonary Fibrosis clinical trial sites?
Recruiting Idiopathic Pulmonary Fibrosis trials list open sites in 36 states and Washington, DC. Pennsylvania, Florida and California have the most, and the table on this page lists every state.
Are there Idiopathic Pulmonary Fibrosis trials for children near me?
Of the 36 Idiopathic Pulmonary Fibrosis trials with a US site, 1 accepts children under 18. Its open sites are in Pennsylvania, Florida and Alabama. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to an Idiopathic Pulmonary Fibrosis clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Idiopathic Pulmonary Fibrosis trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an Idiopathic Pulmonary Fibrosis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Idiopathic Pulmonary Fibrosis: Esbriet (pirfenidone), Jascayd (nerandomilast), Ofev (nintedanib).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.